AAAAAA
Results:
1-21
|
Results: 21
Authors:
NAGATA H
WOROBEC AS
SEMERE T
METCALFE DD
Citation: H. Nagata et al., ELEVATED EXPRESSION OF THE PROTOONCOGENE C-KIT IN PATIENTS WITH MASTOCYTOSIS, Leukemia, 12(2), 1998, pp. 175-181
Authors:
AVILA NA
LING A
METCALFE DD
WOROBEC AS
Citation: Na. Avila et al., MASTOCYTOSIS - MAGNETIC-RESONANCE-IMAGING PATTERNS OF MARROW DISEASE, Skeletal radiology, 27(3), 1998, pp. 119-126
Authors:
KIRSHENBAUM AS
WOROBEC AS
DAVIS TA
GOFF JP
SEMERE T
METCALFE DD
Citation: As. Kirshenbaum et al., INHIBITION OF HUMAN MAST-CELL GROWTH AND DIFFERENTIATION BY INTERFERON GAMMA-1B, Experimental hematology, 26(3), 1998, pp. 245-251
Authors:
SHAH PY
SHARMA V
WOROBEC AS
METCALFE DD
ZWICK DC
Citation: Py. Shah et al., CONGENITAL BULLOUS MASTOCYTOSIS WITH MYELOPROLIFERATIVE DISORDER AND C-KIT MUTATION, Journal of the American Academy of Dermatology, 39(1), 1998, pp. 119-121
Authors:
WOROBEC AS
AKIN C
SCOTT LM
METCALFE DD
Citation: As. Worobec et al., CYTOGENETIC ABNORMALITIES AND THEIR LACK OF RELATIONSHIP TO THE ASP816VAL C-KIT MUTATION IN THE PATHOGENESIS OF MASTOCYTOSIS, Journal of allergy and clinical immunology, 102(3), 1998, pp. 523-524
Authors:
WOROBEC AS
FOSTER BA
SEMERE T
LONGLEY BJ
METCALFE DD
Citation: As. Worobec et al., IDENTIFICATION OF THE MUTATION ASP816TYR IN THE C-KIT RECEPTOR IN AN ADULT PATIENT WITH URTICARIA PIGMENTOSA FROM BIRTH, Journal of allergy and clinical immunology, 101(1), 1998, pp. 893-893
Authors:
WOROBEC AS
SEMERE T
NAGATA H
METCALFE DD
Citation: As. Worobec et al., CLINICAL CORRELATES OF THE PRESENCE OF THE ASP816VAL C-KIT MUTATION IN THE PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WITH MASTOCYTOSIS, Cancer, 83(10), 1998, pp. 2120-2129
Authors:
NAGATA H
OKADA T
WOROBEC AS
SEMERE T
METCALFE DD
Citation: H. Nagata et al., C-KIT MUTATION IN A POPULATION OF PATIENTS WITH MASTOCYTOSIS, International archives of allergy and immunology, 113(1-3), 1997, pp. 184-186
Authors:
HIMMEL MH
HONIG PK
WOROBEC AS
Citation: Mh. Himmel et al., DANGERS OF NONSEDATING ANTIHISTAMINES, Lancet, 350(9070), 1997, pp. 69-69
Authors:
WOROBEC AS
SEMERE T
NAGATA H
METCALFE DD
Citation: As. Worobec et al., THE C-KIT MUTATION IN PATIENTS WITH MASTOCYTOSIS - A FOLLOW-UP-STUDY, Journal of allergy and clinical immunology, 99(1), 1997, pp. 503-503
Authors:
VLIAGOFTIS H
WOROBEC AS
METCALFE DD
Citation: H. Vliagoftis et al., THE PROTOONCOGENE C-KIT AND C-KIT LIGAND IN HUMAN-DISEASE, Journal of allergy and clinical immunology, 100(4), 1997, pp. 435-440
Authors:
AVILA NA
LING A
WOROBEC AS
MICAN JAM
METCALFE DD
Citation: Na. Avila et al., SYSTEMIC MASTOCYTOSIS - CT AND US FEATURES OF ABDOMINAL MANIFESTATIONS, Radiology, 202(2), 1997, pp. 367-372
Authors:
SCHWARTZ LB
SAKAI K
BRADFORD TR
REN S
WOROBEC AS
METCALFE DD
Citation: Lb. Schwartz et al., THE ALPHA-FORM OF HUMAN TRYPTASE PREDOMINATES IN BLOOD AT BASE-LINE IN NORMAL SUBJECTS, AND IS ELEVATED IN THOSE WITH SYSTEMIC MASTOCYTOSIS, Journal of investigative medicine, 44(3), 1996, pp. 298-298
Authors:
WOROBEC AS
KIRSHENBAUM AS
SCHWARTZ LB
METCALFE DD
Citation: As. Worobec et al., TREATMENT OF 3 PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH INTERFERON-ALPHA-2B, Leukemia & lymphoma, 22(5-6), 1996, pp. 501-508
Authors:
AVILA NA
WOROBEC AS
LING A
HIJAZI Y
METCALFE DD
Citation: Na. Avila et al., PULMONARY AND OVARIAN MANIFESTATIONS OF SYSTEMIC MASTOCYTOSIS, American journal of roentgenology, 166(4), 1996, pp. 969-970
Authors:
NAGATA H
WOROBEC AS
METCALFE DD
Citation: H. Nagata et al., IDENTIFICATION OF A POLYMORPHISM IN THE TRANSMEMBRANE DOMAIN OF THE PROTOONCOGENE C-KIT IN HEALTHY-SUBJECTS, Experimental and clinical immunogenetics, 13(3-4), 1996, pp. 210-214
Authors:
HARTMANN K
WOROBEC AS
BIANCHINE PJ
MCKORI YA
METCALFE DD
Citation: K. Hartmann et al., EXPRESSION OF FAS ANTIGEN ON A HUMAN AND ON MURINE MAST-CELL LINES - ANTIBODY TO FAS ANTIGEN INDUCES MAST-CELL APOPTOSIS, Journal of allergy and clinical immunology, 97(1), 1996, pp. 316-316
Authors:
KIRSHENBAUM AS
WOROBEC AS
GOFF JP
DAVIS TA
METCALFE DD
Citation: As. Kirshenbaum et al., INTERFERON-GAMMA BUT NOT INTERFERON-ALPHA INHIBITS THE GROWTH OF MAST-CELLS FROM CD34+ CELLS DERIVED FROM HUMAN MARROW, Journal of allergy and clinical immunology, 95(1), 1995, pp. 296-296
Authors:
WOROBEC AS
KIRSHENBAUM AS
SCHWARTZ LB
METCALFE DD
Citation: As. Worobec et al., TREATMENT OF 3 PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH INTERFERON-ALPHA-2B, Journal of allergy and clinical immunology, 95(1), 1995, pp. 364-364
Authors:
NAGATA H
WOROBEC AS
OH CK
CHOWDHURY BA
TANNENBAUM S
SUZUKI Y
METCALFE DD
Citation: H. Nagata et al., IDENTIFICATION OF A POINT MUTATION IN THE CATALYTIC DOMAIN OF THE PROTOONCOGENE C-KIT IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WHOHAVE MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGIC DISORDER, Proceedings of the National Academy of Sciences of the United Statesof America, 92(23), 1995, pp. 10560-10564
Authors:
SCHWARTZ LB
SAKAI K
BRADFORD TR
REN SL
ZWEIMAN B
WOROBEC AS
METCALFE DD
Citation: Lb. Schwartz et al., THE ALPHA-FORM OF HUMAN TRYPTASE IS THE PREDOMINANT TYPE PRESENT IN BLOOD AT BASE-LINE IN NORMAL SUBJECTS AND IS ELEVATED IN THOSE WITH SYSTEMIC MASTOCYTOSIS, The Journal of clinical investigation, 96(6), 1995, pp. 2702-2710
Risultati:
1-21
|